Safety of Virtual Reality(VR) experiences in patients after hematopoietic stem cell transplantation in clean room or semi-clean room
Not Applicable
Recruiting
- Conditions
- Hematopoietic tumor
- Registration Number
- JPRN-UMIN000046090
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Decreased mental and cognitive function Wounds and skin symptoms on the head Eye symptoms Visual perception disorders other than myopia, hyperopia, astigmatism, etc. Difficulty wearing the Head-Mounted Display and operating the controllers History of epilepsy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Simulator Sickness Questionnaire (at before, immediately after, 30minutes after the VR experience)
- Secondary Outcome Measures
Name Time Method salivary alpha-amylase activity (at before, immediately after, 30minutes after the VR experience) Edmonton Symptom Assessment System Revised Japanese version (at before, immediately after, 30minutes after the VR experience)